Cyclodextrin counteracts obesity associated with various diseases including susceptibility for Covid-19
Obesity has become a worldwide health crisis and is associated with a plethora of comorbidities. Cardiovascular disease (CVD) and type
FDA Approves New KYPROLIS® (SBECD-enabled carfilzomib) Combination Regimen With DARZALEX® (daratumumab) And Dexamethasone
Approval Based on the CANDOR and EQUULEUS Studies in Patients With Relapsed/Refractory Multiple Myeloma Amgen today announced the U.S. Food and
Axsome Therapeutics Completes Successful FDA Pre-NDA Meeting for AXS-07 for the Acute Treatment of Migraine
Axsome Therapeutics, a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, announced that it
A 68-Year-Old Man with Covid-19 and Acute Kidney Injury – Case Records of the Massachusetts General Hospital
The case report discusses the difficulties in the treatment of this patient with acute kidney disease. Acute kidney injury —
Nanotechnology-based antiviral therapeutics
Nanotechnology has emerged as one of the most promising technologies on account of its ability to deal with viral diseases
Antiviral Viroblock masks modified by CD from Wacker
Innovation in Textiles reported on the new masks of Swiss textile innovator HeiQ. The new mask, HeiQ Viroblock NPJ03 was
Biodegradable β ‐Cyclodextrin Conjugated Gelatin Methacryloyl Microneedle for Delivery of Water‐Insoluble Drug
Transdermal drug delivery offers advantages over nonparenteral routes such as bypassing first-pass metabolism and facile administration. Mammalian skin, however, functions
Immobilization of β-CD on a Hyper-Crosslinked Polymer for the Enhanced Removal of Amines from Aqueous Solutions
A simple and efficient strategy to prepare a β-CD-modified hyper-crosslinked styrene-divinyl benzene copolymer (CDM-HCP) was developed. It was applied for
The Lord of the NanoRings: cyclodextrins and the battle against SARSCoV-2
Making a comparison between CDs and the unique Ring of the legendary novel of The Lord of the Rings, J.
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Veklury® (Remdesivir) for the Treatment of COVID-19
Gilead Sciences, Inc. announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration
Pfizer agrees to manufacture Gilead’s coronavirus drug remdesivir
Pfizer has agreed to manufacture and supply Gilead Sciences’ antiviral drug remdesivir, the pharmaceutical giant announced Friday. The multiyear agreement will support efforts to